Biomarkers of Renal Cancer

Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY

The aim of the present study is the identification, in liquid biopsies, of a new molecular panel able to discriminate renal cancer patients from controls, to discriminate patients with a malignant lesion from those with a benign mass, to determine aggressiveness of RCC, and to differentiate the most common histological subtypes of RCC (clear cell, papillary 1, papillary 2, and chromophobe). This new molecular panel will be combined with clinical parameters to provide a screening test and to improve the accuracy and specificity of diagnosis, prognosis, and histological classification of renal cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Men and women over 18 years of age

• Diagnosis of first episode of renal mass

• Caucasian race

• Signed, informed consent

• Men and women over 18 years of age

• Caucasian race

• Living kidney donor or patient with urological functional diseases (e.g. kidney stones, benign prostate hypertrophy, etc..)

• Signed, informed consent

Locations
Other Locations
Italy
Azienda Ospedaliera Universitaria Careggi
RECRUITING
Firenze
IRCCS San Raffaele
RECRUITING
Milano
Azienda Ospedaliera Universitaria San Luigi Gonzaga
RECRUITING
Orbassano
Spain
Fundació Puigvert
RECRUITING
Barcelona
Contact Information
Primary
Francesco Trevisani
francesco.trevisani@biorek.eu
0226435857
Backup
Alessandra Cinque
alessandra.cinque@biorek.eu
0226435857
Time Frame
Start Date: 2019-06-11
Estimated Completion Date: 2026-06
Participants
Target number of participants: 1000
Treatments
Renal-mass patients
Patients diagnosed with a first episode of renal mass attending the urology department.
Control subjects
Patients affected by urological functional diseases or living kidney donor.
Sponsors
Leads: Biorek S.R.L.

This content was sourced from clinicaltrials.gov